Helicobacter pylori in Iran: A systematic review on the association of genotypes and gastroduodenal diseases

Journal of Research in Medical Sciences

Volumn 17, Issue 3, 2012, Pages 1-14

  Hosseini, Elham ^a   Poursina, Farkhondeh ^b   van de Wiele, Tom ^a   Safaei, Hajieh Ghasemian ^b   Adibi, Peyman ^c  

^a GHENT UNIVERSITY   (Belgium)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CagA; Gastroduodenal; Genotyping; H. pylori; Iran; VacA; Virulence

Indexed keywords

CAGA PROTEIN; VIRULENCE FACTOR;

ABDOMINAL PAIN; ATROPHY; BABA GENE; BACTERIAL GENE; BACTERIAL VIRULENCE; CHRONIC GASTRITIS; CYTOTOXIN ASSOCIATED GENE A; CYTOTOXIN ASSOCIATED GENE E; DISEASE ASSOCIATION; DUODENUM DISEASE; DUPA GENE; DYSPLASIA; ESOPHAGUS CANCER; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOM GENE; HUMAN; ICEA GENE; INTESTINE METAPLASIA; IRAN; OIPA GENE; PEPTIC ULCER; REVIEW; STOMACH CANCER; SYSTEMATIC REVIEW; VACUOLATING CYTOTOXIN GENE A;

EID: 84859120994     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Peek RM, Jr., Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002; 2(1): 28-37.
2. Blaser MJ. Ecology of Helicobacter pylori in the human stomach. J Clin Invest 1997; 100(4): 759-62.
3. Alizadeh AH, Ansari S, Ranjbar M, Shalmani HM, Habibi I, Firouzi M, et al. Seroprevalence of Helicobacter pylori in Nahavand: a population-based study. East Mediterr Health J 2009; 15(1): 129-35.
4. Karbalaei Ali M, Mohabati Mobarez A, Amini M, Teymournejad O. The role of smoking and oral hygiene in prevalence of Helicobacter pylori in dental plaque and stomach of dyspeptic patients. Am J Epidemiol 2011; 173: S24.
5. Shokrzadeh L, Baghaei K, Mirsattari D, Mashayekhi R, Zojaji H, Zali MR. Investigation of Helicobacter pylori in dyspeptic patients and its relationship with Iranian life cycle. Int J Infect Dis 2010; 14(suppl 1): e 214.
6. Farshad S, Japoni A, Alborzi A. Helicobacter pylori and extradigestive disorders in the past 10 years. IRCMJ 2009; 11(2): 123-132.
7. Kamangar F, Sheikhattari P, Mohebtash M. Helicobacter pylori and its effects on human health and disease. Arch Iran Med 2011; 14(3): 192-9.
8. Tanih NF, Ndip LM, Clarke AM, Ndip RN. An overview of pathogenesis and epidemiology of Helicobacter pylori infection. African Journal of Microbiology 2012; 4(6): 426-36.
9. Malekzadeh R, Sotoudeh M, Derakhshan MH, Mikaeli J, Yazdanbod A, Merat S, et al. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol 2004; 57(1): 37-42.
10. Mikaeli J, Valizadeh M, Khoncheh A, Malekzadeh R, Eshraghian MR, Alizadeh BZ, et al. Helicobacter pylori prevalence in two Iranian provinces with high and low incidence of gastric carcinoma. Gastroenterology 2000; 116(4): A254.
11. IARC. Working group on the evaluation of carcinogenic risks to humans, schistosomes, liver flukes, helicobacter pylori. IARC monograph on the evaluation of carcinogenic risks to humans: Schitosomes, liver flukes and Helicobacter pylori. Lyon: IARC; 1994. p. 61.
12. Ebrahimi Daryani N, Taher M, Shirzad S. Helicobacter pylori infection: A review. Iranian Journal of Clinical Infectious Disease 2011; 6(1): 56-64.
13. Megraud F. Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther 1997; 11(Suppl 1): 43-53.
14. Fakheri H, Malekzadeh R, Merat S, Khatibian M, Fazel A, Alizadeh BZ, et al. Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate. Aliment Pharmacol Ther 2001; 15(3): 411-6.
15. Zendehdel N, Nasseri-Moghaddam S, Malekzadeh R, Massarrat S, Sotoudeh M, Siavoshi F. Helicobacter pylori reinfection rate 3 years after successful eradication. J Gastroenterol Hepatol 2005; 20(3): 401-4.
16. Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H. Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroenterol Hepatol 1995; 7(5): 427-33.
17. Sotoudeh M, Derakhshan MH, Abedi-Ardakani B, Nouraie M, Yazdanbod A, Tavangar SM, et al. Critical role of Helicobacter pylori in the pattern of gastritis and carditis in residents of an area with high prevalence of gastric cardia cancer. Dig Dis Sci 2008; 53(1): 27-33.
18. Siavoshi F, Asgharzadeh A, Ghadiri H, Massarrat S, Latifi-Navid S, Zamani M. Helicobacter pylori genotypes and types of gastritis in first-degree relatives of gastric cancer patients. Int J Med Microbiol 2011; 301(6): 506-12.
19. Douraghi M, Talebkhan Y, Zeraati H, Ebrahimzadeh F, Nahvijoo A, Morakabati A, et al. Multiple gene status in Helicobacter pylori strains and risk of gastric cancer development. Digestion 2009; 80(3): 200-7.
20. Warren JR. Unidentified curved Bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1(8336): 1273.
21. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118(12): 3030-44.
22. Malekzadeh R, Derakhshan MH, Malekzadeh Z. Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med 2009; 12(6): 576-83.
23. Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, et al. Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer 2003; 107(1): 113-8.
24. Ghadimi R, Taheri H, Suzuki S, Kashifard M, Hosono A, Esfandiary I, et al. Host and environmental factors for gastric cancer in Babol, the Caspian Sea Coast, Iran. Eur J Cancer Prev 2007; 16(3): 192-5.
25. Danesh J. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther 1999; 13(7): 851-6.
26. Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila) 2008; 1(5): 329-38.
27. Shahabi S, Rasmi Y, Jazani NH, Hassan ZM. Protective effects of Helicobacter pylori against gastroesophageal reflux disease may be due to a neuroimmunological anti-inflammatory mechanism. Immunol Cell Biol 2008; 86(2): 175-8.
28. Abdollahi A, Morteza A, Khalilzadeh O, Zandieh A, Asgarshirazi M. The role of Helicobacter pylori infection in gastro-esophageal reflux in Iranian children. Ann Trop Paediatr 2011; 31(1): 53-7.
29. Somi MH, Fattahi E, Fouladi RF, Karimi M, Bonyadi R, Baballou Z. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of erosive GERD. Saudi Med J 2008; 29(3): 393-6.
30. Masoodpoor N, Darakhshan, Sheikhvatan M. Helicobacter pylori infection in Iranian children with recurrent abdominal pain. Trop Gastroenterol 2008; 29(4): 221-3.
31. Dolatkhah R, Khoshbaten M, Asvadi Kermani I, Sanaat Z, Bonyadi MR, Ghojazadeh M, et al. Upper gastrointestinal bleeding in patients with haemophilia in Iran: prevalence of Helicobacter pylori infection. Proceedings of the 53rd ASH Anual Meeting and Exposition; 2011 Dec 10-13; San Diego, USA.
32. Chitsazi MT, Fattahi E, Farahani RM, Fattahi S. Helicobacter pylori in the dental plaque: is it of diagnostic value for gastric infection? Med Oral Patol Oral Cir Bucal 2006; 11(4): E325-E328.
33. Atherton JC. The clinical relevance of strain types of Helicobacter pylori. Gut 1997; 40(6): 701-3.
34. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, et al. caga pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Nat Acad Sci USA 1996; 93(25): 14648-53.
35. Fallone CA, Beech R, Barkun A, Gottke M, Loo V, Nguyen T. The Helicobacter pylori vacA s1 genotype and the cagE gene are associated with gastroduodenal disease. Gut 1998; 43(Suppl): 19A.
36. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000; 287(5457): 1497-500.
37. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55(10): 2111-5.
38. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995; 87(23): 1777-80.
39. Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Nat Acad Sci USA 2000; 97(3): 1263-8.
40. Douraghi M, Mohammadi M, Shirazi MH, Oghalaie A, Kashani SS, Mohagheghi MA, et al. Simultaneous detection of caga and cage of Helicobacter pylori strains recovered from Iranian patients with different gastroduodenal diseases. Iranian J Publ Health 2009; 38(2): 98-105.
41. Salehi Z, Jelodar MH, Rassa M, Ahaki M, Mollasalehi H, Mashayekhi F. Helicobacter pylori cagA status and peptic ulcer disease in Iran. Dig Dis Sci 2009; 54(3): 608-13.
42. Ghasemian Safaei H, Tavakkoli H, Mojtahedi A, Salehi R, Soleimani B, Pishva E. Correlation of cagA positive Helicobacter pylori infection with clinical outcomes in Alzahra hospital, Isfahan, Iran. J Res Med Sci 2008; 13(4): 195-201.
43. Yamaoka Y, Kodama T, Kashima K, Graham DY, Sepulveda AR. Variants of the 3′ region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol 1998; 36(8): 2258-63.
44. Azuma T, Yamakawa A, Yamazaki S, Fukuta K, Ohtani M, Ito Y, et al. Correlation between variation of the 3′ region of the cagA gene in Helicobacter pylori and disease outcome in Japan. J Infect Dis 2002; 186(11): 1621-30.
45. Shokrzadeh L, Baghaei K, Yamaoka Y, Dabiri H, Jafari F, Sahebekhtiari N, et al. Analysis of 3′-end variable region of the cagA gene in Helicobacter pylori isolated from Iranian population. J Gastroenterol Hepatol 2010; 25(1): 172-7.
46. Talebkhan Y, Mohammadi M, Mohagheghi MA, Vaziri HR, Eshagh HM, Mohajerani N, et al. cagA gene and protein status among Iranian Helicobacter pylori strains. Dig Dis Sci 2008; 53(4): 925-32.
47. Figueiredo C, Van Doorn LJ, Nogueira C, Soares JM, Pinho C, Figueira P, et al. Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. Scand J Gastroenterol 2001; 36(2): 128-35.
48. Mattar R, Marques SB, Monteiro MS, Dos Santos AF, Iriya K, Carrilho FJ. Helicobacter pylori cag pathogenicity island genes: clinical relevance for peptic ulcer disease development in Brazil. J Med Microbiol 2007; 56(1): 9-14.
49. Baghaei K, Shokrzadeh L, Jafari F, Dabiri H, Yamaoka Y, Bolfion M, et al. Determination of Helicobacter pylori virulence by analysis of the cag pathogenicity island isolated from Iranian patients. Dig Liver Dis 2009; 41(9): 634-8.
50. Baghai K, Shokrzadeh L. Important marker of cagI and cagII in Helicobacter pylori isolated from dyspeptic patients in Iran. Int J Infect Dis 2008; 12(suppl): E209-E210.
51. Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh HM, et al. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 2007; 133(3): 926-36.
52. Tee W, Lambert JR, Dwyer B. Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases. J Clin Microbiol 1995; 33(5): 1203-5.
53. Galmiche A, Rassow J, Doye A, Cagnol S, Chambard JC, Contamin S, et al. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J 2000; 19(23): 6361-70.
54. Pai R, Cover TL, Tarnawski AS. Helicobacter pylori vacuolating cytotoxin (VacA) disorganizes the cytoskeletal architecture of gastric epithelial cells. Biochem Biophys Res Commun 1999; 262(1): 245-50.
55. Douraghi M, Saberi Kashani S, Shokrgozar MA, Shirazi MH, Mohagheghi MA, Mohammad M. Characterization of the vacuolating cytotoxin in Helicobacter pylori strains isolated from Iran. Cell Journal 2010; 12(1): 1-6.
56. Siavoshi F, Malekzadeh R, Daneshmand M, Smoot DT, Ashktorab H. Association between Helicobacter pylori Infection in gastric cancer, ulcers and gastritis in Iranian patients. Helicobacter 2004; 9(5): 470.
57. Doosti A, Ghasemi-Dehkordi P. Helicobacter pylori vacA genotypes in Shahrekordian (Iran) H. pylori-positive patients. Res j Biol Sci 2009; 4(1): 11-5.
58. Mohammadi M, Oghalaie A, Mohajerani N, Massarrat S, Nasiri M, Bennedsen M, et al. Prevalence of Helicobacter pylori vacuolating cytotoxin and its allelic mosaicism as a predictive marker for Iranian dyspeptic patients. Bull Soc Pathol Exot 2003; 96(1): 3-5.
59. Siavoshi F, Malekzadeh R, Daneshmand M, Ashktorab H. Helicobacter pylori endemic and gastric disease. Dig Dis Sci 2005; 50(11): 2075-80.
60. Salehi Z, Abadi AS, Ismail PB, Kqueen CY, Jelodar MH, Kamalidehghan B. Evaluation of Helicobacter pylori vacA genotypes in Iranian patients with peptic ulcer disease. Dig Dis Sci 2009; 54(11): 2399-403.
61. Jafari F, Shokrzadeh L, Dabiri H, Baghaei K, Yamaoka Y, Zojaji H, et al. vacA genotypes of Helicobacter pylori in relation to cagA status and clinical outcomes in Iranian populations. Jpn J Infect Dis 2008; 61(4): 290-3.
62. Molaei M, Foroughi F, Mashayekhi R, Haghazali M, Zojaji H, Jafari F, et al. cagA status and vacA subtypes of Helicobacter pylori in relation to histopathologic findings in Iranian population. Indian J Pathol Microbiol 2010; 53(1): 24-7.
63. Zali MR, Jafari F, Baghbani-arani F, Aslani MM, Rostaminejad M, Haghazali M, et al. Prevalence of cagA and vacA genes in Helicobacter pylori isolates from patients with gastroduodenal diseases in Tehran, Iran (2006). Helicobacter 2006; 11: 16-7.
64. Covacci A, Telford JL, Del GG, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999; 284(5418): 1328-33.
65. Van Doorn LJ, Figueiredo C, Sanna R, Plaisier A, Schneeberger P, de BW, et al. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 1998; 115(1): 58-66.
66. Dabiri H, Maleknejad P, Yamaoka Y, Feizabadi MM, Jafari F, Rezadehbashi M, et al. Distribution of Helicobacter pylori cagA, cagE, oipA and vacA in different major ethnic groups in Tehran, Iran. J Gastroenterol Hepatol 2009; 24(8): 1380-6.
67. Dabiri H, Bolfion M, Mirsalehian A, Rezadehbashi M, Jafari F, Shokrzadeh L, et al. Analysis of Helicobacter pylori genotypes in Afghani and Iranian isolates. Pol J Microbiol 2010; 59(1): 61-6.
68. Hussein NR, Mohammadi M, Talebkhan Y, Doraghi M, Letley DP, Muhammad MK, et al. Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: potential importance of regional differences in H. pyloriassociated disease. J Clin Microbiol 2008; 46(5): 1774-9.
69. Karbalayi M, Khodadad S. Isolation and characteristic distribution pattern of cagA plus Helicobacter pylori in dental plaque of dyspeptic patients. Int J Infect Dis 2010; 14(suppl): E213.
70. Momtaz H, Souod N, Dabiri H. Comparison of the virulence factors of Helicobacter pylori isolated in stomach and saliva in Iran. Am J Med Sci 2010; 340(5): 345-9.
71. Fujimoto S, Olaniyi OO, Arnqvist A, Wu JY, Odenbreit S, Haas R, et al. Helicobacter pylori BabA expression, gastric mucosal injury, and clinical outcome. Clin Gastroenterol Hepatol 2007; 5(1): 49-58.
72. Ghasemian Safaei H, Havaei SA, Tavakkoli H, Eshaghei M, Navabakbar F, Salehei R. Relation of babA2 genotype of Helicobacter pylori infection with chronic active gastritis, duodenal ulcer and non-cardia gastric cancer in Alzahra hospital, Isfahan, Iran. JJM 2010; 3(3): 93-8.
73. Talebi Bezmin AA, Taghvaei T, Mohabbati MA, Vaira G, Vaira D. High correlation of babA2-positive strains of Helicobacter pylori with the presence of gastric cancer. Intern Emerg Med 2011. [Epub ahead of print].
74. Kashani SS, Douraghi M, Talebkhan Y, Bababeik M, Esmaeili M, Mohammadi M. Relationship between Helicobacter pylori babA and babB status with other virulence factors and their correlation with disease outcome in Iran. Int J Infect Dis 2008; 12: E214.
75. Talebi Bezmin Abadi A, Mohabati Mobarez A, Taghavaei T. An investigation of the prevalence of iceA genotypes in Helicobacter pylori strains isolated from peptic ulcer patients in Sari (2008). AMUJ 2010; 13(3): 84-90.
76. Shokri Shirvani J, Rajabnia R, Tohidi F, Asmar M, Taheri H. Outbreak of cagA and iceA in H. pylori strains isolated from patients with gastro duodenal diseases in Babol city. JBUMS 2008; 10(1): 46-53.
77. Yamaoka Y, Kikuchi S, el-Zimaity HM, Gutierrez O, Osato MS, Graham DY. Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology 2002; 123(2): 414-24.
78. Lu H, Hsu PI, Graham DY, Yamaoka Y. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 2005; 128(4): 833-48.
79. Douraghi M, Mohammadi M, Oghalaie A, Abdirad A, Mohagheghi MA, Hosseini ME, et al. dupA as a risk determinant in Helicobacter pylori infection. J Med Microbiol 2008; 57(5): 554-62.
80. Alm RA, Bina J, Andrews BM, Doig P, Hancock RE, Trust TJ. Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families. Infect Immun 2000; 68(7): 4155-68.
81. Jung SW, Sugimoto M, Graham DY, Yamaoka Y. homB status of Helicobacter pylori as a novel marker to distinguish gastric cancer from duodenal ulcer. J Clin Microbiol 2009; 47(10): 3241-5.
82. Oleastro M, Cordeiro R, Ferrand J, Nunes B, Lehours P, Carvalho-Oliveira I, et al. Evaluation of the clinical significance of homB, a novel candidate marker of Helicobacter pylori strains associated with peptic ulcer disease. J Infect Dis 2008; 198(9): 1379-87.
83. Talebi Bezmin AA, Rafiei A, Ajami A, Hosseini V, Taghvaei T, Jones KR, et al. Helicobacter pylori homB, but not cagA, is associated with gastric cancer in Iran. J Clin Microbiol 2011; 49(9): 3191-7.
84. Safaei HG, Tavakkoli H, Mojtahedi A, Salehei R, Soleimani B, Pishva E. Correlation of cagA positive Helicobacter pylori infection with clinical outcomes in Alzahra hospital, Isfahan, Iran. J Res Med Sci 2008; 13(4): 196-201.
85. Maeda S, Ogura K, Yoshida H, Kanai F, Ikenoue T, Kato N, et al. Major virulence factors, vacA and cagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut 1998; 42(3): 338-43.
86. Yamaoka Y, Souchek J, Odenbreit S, Haas R, Arnqvist A, Boren T, et al. Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori. J Clin Microbiol 2002; 40(6): 2244-6.
87. Sugimoto M, Zali MR, Yamaoka Y. The association of vacA genotypes and Helicobacter pylori-related gastroduodenal diseases in the Middle East. Eur J Clin Microbiol Infect Dis 2009; 28(10): 1227-36.
88. Kamali-Sarvestani E, Bazargani A, Masoudian M, Lankarani K, Taghavi AR, Saberifiroozi M. Association of H. pylori cagA and vacA genotypes and IL-8 gene polymorphisms with clinical outcome of infection in Iranian patients with gastrointestinal diseases. World J Gastroenterol 2006; 12(32): 5205-10.
89. Wong BC, Yin Y, Berg DE, Xia HH, Zhang JZ, Wang WH, et al. Distribution of distinct vacA, cagA and iceA alleles in Helicobacter pylori in Hong Kong. Helicobacter 2001; 6(4): 317-24.
90. Fallahi GH, Maleknejad S. Helicobacter pylori culture and antimicrobial resistance in Iran. Indian J Pediatr 2007; 74(2): 127-30.
91. Farshad S, Alborzi A, Japoni A, Ranjbar R, Hosseini AK, Badiee P, et al. Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran. World J Gastroenterol 2010; 16(45): 5746-51.
92. Sirous M, Mehrabadi JF, Daryani NE, Eshraghi S, Hajikhani S, Shirazi MH. Prevalence of antimicrobial resistance in Helicobacter pylori isolates from Iran. Afr J Biotechnol 2010; 9(36): 5962-5.